Celeste Di Meo

Dr. Celeste Di Meo

Università della Campania 'Luigi Vanvitelli'

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Carbohydrate Polymers
Verified
Journal Article
Closed access
RGRossella Di Guida
Rossella Di Guida
CACasillo Angela
Casillo Angela
ASAntonietta Stellavato
Antonietta Stellavato
KSKawai Soichiro
Kawai Soichiro
TOTakuya Ogawa
Takuya Ogawa
Maria Michela CorsaroMaria Michela Corsaro
Maria Michela Corsaro

31 October 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
CMCeleste Di Meo
Celeste Di Meo
ASAntonietta Stellavato
Antonietta Stellavato
MDMaria D'AGostino
Maria D'AGostino
ADAntonella D'Agostino
Antonella D'Agostino
chiara Schiraldichiara Schiraldi
chiara Schiraldi
AGAnnalisa La Gatta
Annalisa La Gatta

22 September 2021 in Polymers
Verified
Journal Article
Open access
PDF file
AGAnnalisa La Gatta
Annalisa La Gatta
ASAntonietta Stellavato
Antonietta Stellavato
VVValentina Vassallo
Valentina Vassallo
CMCeleste Di Meo
Celeste Di Meo
GGiuseppe Toro
Giuseppe Toro
chiara Schiraldichiara Schiraldi
chiara Schiraldi
In this research work, viscosupplements based on linear, derivatized, crosslinked and complexed HA forms were extensively examined, providing data on the hydrodynamic parameters for the water-soluble-HA-fraction, rheology, sensitivity to enzymatic hydrolysis and capacity to modulate specific biomarkers’ expression in human pathological chondrocytes and synoviocytes. Soluble HA ranged from 0 to 32 mg/mL and from 150 to 1330 kDa MW. The rheological behavior spanned from purely elastic to viscoelastic, suggesting the diversity of the categories that are suitable for restoring specific/different features of the healthy synovial fluid. The rheological parameters were reduced in a diverse manner upon dilution and hyaluronidases action, indicating different durations of the viscosupplementation effect. Bioactivity was found for all the samples, increasing the expression of different matrix markers (e.g., hyaluronan-synthase); however, the hybrid cooperative complexes performed better in most of the experiments. Hybrid cooperative complexes improved COLII mRNA expression (~12-fold increase vs. CTR), proved the most effective at preserving cell phenotype. In addition, in these models, the HA samples reduced inflammation. IL-6 was down-regulated vs. CTR by linear and chemically modified HA, and especially by hybrid complexes. The results represent the first comprehensive panel of data directly comparing the diverse HA forms for intra-articular injections and provide valuable information for tailoring products’ clinical use as well as for designing new, highly performing HA-formulations that can address specific needs.

Verified
Journal Article
Open access
PDF file
VVValentina Vassallo
Valentina Vassallo
CMCeleste Di Meo
Celeste Di Meo
Nicola AlessioNicola Alessio
Nicola Alessio
AGAnnalisa La Gatta
Annalisa La Gatta
GFGiuseppe Andrea Ferraro
Giuseppe Andrea Ferraro
chiara Schiraldichiara Schiraldi
chiara Schiraldi
Cells and extracts derived from adipose tissue are gaining increasing attention not only in plastic surgery and for aesthetic purposes but also in regenerative medicine. The ability of hyaluronan (HA) to support human adipose stromal cell (hASC) viability and differentiation has been investigated. However, the compatibility of adipose tissue with HA-based formulation in terms of biophysical and rheological properties has not been fully addressed, although it is a key feature for tissue integration and in vivo performance. In this study, the biophysical and biochemical properties of highly concentrated (45 mg/mL) high/low-molecular-weight HA hybrid cooperative complex were assessed with a further focus on the potential application in adipose tissue augmentation/regeneration. Specifically, HA hybrid complex rheological behavior was observed in combination with different adipose tissue ratios, and hyaluronidase-catalyzed degradation was compared to that of a high-molecular-weight HA (HHA). Moreover, the HA hybrid complex’s ability to induce in vitro hASCs differentiation towards adipose phenotype was evaluated in comparison to HHA, performing Oil Red O staining and analyzing gene/protein expression of PPAR-γ, adiponectin, and leptin. Both treatments supported hASCs differentiation, with the HA hybrid complex showing better results. These outcomes may open new frontiers in regenerative medicine, supporting the injection of highly concentrated hybrid formulations in fat compartments, eventually enhancing residing staminal cell differentiation and improving cell/growth factor persistence towards tissue regeneration districts.

9 October 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
VVValentina Vassallo
Valentina Vassallo
CMCeleste Di Meo
Celeste Di Meo
GGiuseppe Toro
Giuseppe Toro
AAAlberto Alfano
Alberto Alfano
GIGiovanni Iolascon
Giovanni Iolascon
chiara Schiraldichiara Schiraldi
chiara Schiraldi
Currently, chondroitin sulfate (CS) and hyaluronic acid (HA) pharma-grade forms are used for osteoarthritis (OA) management, CS as an oral formulations component, and HA as intra-articular injective medical devices. Recently, unsulfated chondroitin, obtained through biofermentative (BC) manufacturing, has been proposed for thermally stabilized injective preparation with HA. This study aimed to highlight the specific properties of two commercial injective medical devices, one based on HA/BC complexes and the other containing HA, extractive CS, and cyclodextrins, in order to provide valuable information for joint disease treatments. Their biophysical and biomechanical features were assayed; in addition, biological tests were performed on human pathological chondrocytes. Rheological measurements displayed similar behavior, with a slightly higher G′ for HA/BC, which also proved superior stability to the hyaluronidase attack. Both samples reduced the expression of specific OA-related biomarkers such as NF-kB, interleukin 6 (IL-6), and metalloprotease-13 (MMP-13). Moreover, HA/BC better ensured chondrocyte phenotype maintenance by up-regulating collagen type 2A1 (COLII) and aggrecan (AGN). Notwithstanding, the similarity of biomolecule components, the manufacturing process, raw materials characteristics, and specific concentration resulted in affecting the biomechanical and, more interestingly, the biochemical properties, suggesting potential better performances of HA/BC in joint disease treatment.

19 November 2021 in Marine Drugs
Verified
Journal Article
Open access
PDF file
RGRossella Di Guida
Rossella Di Guida
CACasillo Angela
Casillo Angela
ASAntonietta Stellavato
Antonietta Stellavato
CMCeleste Di Meo
Celeste Di Meo
KSKawai Soichiro
Kawai Soichiro
Maria Michela CorsaroMaria Michela Corsaro
Maria Michela Corsaro
Lipopolysaccharides (LPS) are surface glycoconjugates embedded in the external leaflet of the outer membrane (OM) of the Gram-negative bacteria. They consist of three regions: lipid A, core oligosaccharide (OS), and O-specific polysaccharide or O-antigen. Lipid A is the glycolipid endotoxin domain that anchors the LPS molecule to the OM, and therefore, its chemical structure is crucial in the maintenance of membrane integrity in the Gram-negative bacteria. In this paper, we reported the characterization of the lipid A and OS structures from Pseudoalteromonas nigrifaciens Sq02-Rifr, which is a psychrotrophic Gram-negative bacterium isolated from the intestine of Seriola quinqueradiata. The immunomodulatory activity of both LPS and lipid A was also examined.